SUMO2 Protein - Small Ubiquitin-Like Modifier 2

SUMO2 Protein — Small Ubiquitin-Like Modifier 2

Introduction

SUMO2 (Small Ubiquitin-Like Modifier 2) is a member of the SUMO family of ubiquitin-like proteins that play critical roles in regulating protein function, localization, and stability through a reversible post-translational modification process called SUMOylation. This modification regulates numerous cellular processes including transcription, DNA repair, mitochondrial function, and protein degradation. Growing evidence implicates SUMOylation dysregulation in the pathogenesis of neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Huntington's disease. [@geissfriedlander2007]

SUMO2 Protein — Small Ubiquitin-Like Modifier 2

Introduction

SUMO2 (Small Ubiquitin-Like Modifier 2) is a member of the SUMO family of ubiquitin-like proteins that play critical roles in regulating protein function, localization, and stability through a reversible post-translational modification process called SUMOylation. This modification regulates numerous cellular processes including transcription, DNA repair, mitochondrial function, and protein degradation. Growing evidence implicates SUMOylation dysregulation in the pathogenesis of neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Huntington's disease. [@geissfriedlander2007]

<div class="infobox infobox-protein"> [@tatham2008]
<table> [@hay2013]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">SUMO2 Protein</th></tr> [@krumova2013]
<tr><td><strong>Protein Name</strong></td><td>Small Ubiquitin-Like Modifier 2</td></tr> [@bersch2014]
<tr><td><strong>Gene</strong></td><td>[SUMO2](/genes/sumo2)</td></tr> [@li2016]
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P61956" target="_blank">P61956</a></td></tr> [@rott2017]
<tr><td><strong>Alternative Names</strong></td><td>SUMO-2, Sentrin-2, SMT3C</td></tr> [@kim2016]
<tr><td><strong>Molecular Weight</strong></td><td>10.9 kDa</td></tr>
<tr><td><strong>Length</strong></td><td>95 amino acids</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Nucleus, Cytoplasm, Nuclear Pore Complex</td></tr>
<tr><td><strong>Protein Family</strong></td><td>SUMO family, Ubiquitin-like proteins</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/cardiac" style="color:#ef9a9a">Cardiac</a>, <a href="/wiki/dementia" style="color:#ef9a9a">Dementia</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">25 edges</a></td>
</tr>
</table>
</div>

Overview

SUMO2 is a member of the SUMO (Small Ubiquitin-Like Modifier) protein family that mediates reversible post-translational modification through a process called SUMOylation [1](https://doi.org/10.1016/j.tibs.2011.06.002). Unlike ubiquitination, which typically targets proteins for degradation, SUMOylation modulates protein function, localization, and interactions in diverse ways. SUMO2 is particularly important for stress-responsive SUMOylation, as it becomes rapidly conjugated to proteins in response to cellular stress including heat shock, oxidative stress, and DNA damage [2](https://doi.org/10.1016/j.molcel.2012.10.016).

The SUMOylation pathway involves an E1 activating enzyme (SAE1/SAE2), an E2 conjugating enzyme (UBC9), and various E3 ligases that provide substrate specificity. SUMOylation is reversible through the action of SUMO-specific proteases (SENPs) that cleave SUMO from substrates [3](https://doi.org/10.1038/nrm3336). This dynamic modification regulates hundreds of proteins involved in transcription, DNA repair, mitochondrial function, and protein quality control.

In the nervous system, SUMOylation plays crucial roles in neuronal development, synaptic plasticity, and response to neurodegeneration. Dysregulated SUMOylation has been implicated in multiple neurodegenerative diseases, where it affects the aggregation, clearance, and toxicity of disease-associated proteins including [amyloid-beta](/proteins/amyloid-beta), [tau](/proteins/tau), [alpha-synuclein](/proteins/alpha-synuclein), and [huntingtin](/proteins/huntingtin) [4](https://doi.org/10.1016/j.tins.2015.08.001).

Structure

SUMO2 shares structural homology with ubiquitin but has distinct features:

• N-terminal region: Contains a flexible N-terminus with multiple lysine residues that serve as SUMO chain attachment sites
• Ubiquitin-like fold: Compact globular domain consisting of a β-sheet and α-helices
• C-terminal di-glycine motif: Required for conjugation to target proteins
• ψKxE motif: Consensus SUMOylation site in substrates (ψ = hydrophobic, K = lysine, x = any amino acid, E = glutamic acid)

Normal Function

Stress-Responsive SUMOylation

SUMO2 is the primary SUMO paralog involved in stress-responsive SUMOylation:

• Heat shock response: Rapid conjugation of SUMO2 to misfolded proteins
• Oxidative stress: SUMO2 modification protects proteins from oxidative damage
• DNA damage response: SUMO2ylation of DNA repair proteins coordinates repair
• Mitotic regulation: SUMO2 dynamics regulate mitotic progression

Transcriptional Regulation

SUMO2ylation controls transcription factor activity:

• Repression: Many transcription factors are repressed when SUMO2ylated
• Coactivator recruitment: SUMOylation affects coactivator interactions
• Chromatin remodeling: SUMOylated chromatin regulators control gene expression

Mitochondrial Function

SUMO2ylation regulates mitochondrial dynamics:

• Mitophagy: PINK1 and Parkin-mediated mitophagy involves SUMOylation
• Mitochondrial transport: SUMOylation of mitochondrial proteins affects distribution
• Metabolism: Mitochondrial enzyme SUMOylation modulates metabolic flux

Protein Quality Control

SUMO2 plays a role in protein homeostasis:

• Aggregation prevention: SUMO2ylation of misfolded proteins prevents aggregation
• Proteasomal degradation: SUMO chains can target proteins for degradation
• [Autophagy](/entities/autophagy): Selective autophagy involves SUMOylated substrates

Role in Neurodegenerative Diseases

Alzheimer's Disease

SUMO2ylation is significantly altered in Alzheimer's disease:

• Amyloid-beta metabolism: SUMO2ylation of [APP](/entities/app-protein) and secretases affects amyloid-beta production
• Tau pathology: SUMO2ylation of tau influences its aggregation and clearance
• Synaptic dysfunction: Altered SUMOylation affects synaptic proteins
• Oxidative stress: SUMO2 response to oxidative stress is impaired in AD

Parkinson's Disease

SUMO2 plays complex roles in PD pathogenesis:

• Alpha-synuclein: SUMO2ylation affects alpha-synuclein aggregation and toxicity
• LRRK2: LRRK2 is regulated by SUMO2ylation, affecting its kinase activity
• PINK1/Parkin pathway: Mitophagy involves SUMO1/SUMO2 modifications
• Mitochondrial dysfunction: SUMO2ylation of mitochondrial proteins is altered

Huntington's Disease

SUMO2 dysregulation contributes to Huntington's disease:

• Huntingtin aggregation: SUMO2ylation of mutant huntingtin affects its aggregation
• Transcription dysregulation: SUMO2ylated transcription factors are sequestered
• Mitochondrial dysfunction: Altered SUMOylation affects mitochondrial proteins
• Excitotoxicity: SUMO2ylation of glutamate receptors affects excitotoxic response

Amyotrophic Lateral Sclerosis (ALS)

SUMO2 plays a role in ALS pathogenesis:

• [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology: TDP-43 is regulated by SUMO2ylation
• RNA metabolism: SUMO2ylation of RNA-binding proteins is altered
• Oxidative stress: Cellular stress response via SUMO2 is impaired

Therapeutic Implications

Targeting SUMOylation represents a therapeutic strategy:

Biomarker Applications

SUMO2 and SUMOylated proteins serve as biomarkers:

• Disease progression: SUMO2ylation levels correlate with disease severity
• Therapeutic response: SENP activity indicates treatment efficacy
• Stress markers: SUMO2 chain formation indicates cellular stress

See Also

• [SUMO2 Gene](/genes/sumo2)
• [SUMOylation](/mechanisms/sumoylation)
• [Protein Ubiquitination](/mechanisms/protein-ubiquitination)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Huntington's Disease](/diseases/huntington-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/als)
• [TDP-43](/proteins/tdp-43)

Background

The study of Sumo2 Protein Small Ubiquitin Like Modifier 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References